# FDA Inspection 1039082 - SpecGx, LLC - January 26, 2018

Source: https://www.keypedia.com/records/fda_inspections/specgx-llc/162223b2-122b-467c-8cda-4fb88db77e76
Source feed: FDA_Inspections

> FDA Inspection 1039082 for SpecGx, LLC on January 26, 2018. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1039082
- Company Name: SpecGx, LLC
- Inspection Date: 2018-01-26
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1220234 - 2023-09-18](https://www.keypedia.com/records/fda_inspections/specgx-llc/3e43114c-0b19-49da-9cf2-9cc14aa3651d)
- [FDA Inspection 1122446 - 2020-03-16](https://www.keypedia.com/records/fda_inspections/specgx-llc/ee22c8dc-7648-402a-8c45-f3939a421bf3)
- [FDA Inspection 1085155 - 2019-03-06](https://www.keypedia.com/records/fda_inspections/specgx-llc/5abf6c00-0093-42c8-9ef4-d63b6344a1dc)

Company: https://www.keypedia.com/companies/specgx-llc/ee069c18-3128-4bbe-9c13-768b4837810f

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c